Perpetua Medical AB (publ)

STO-PERP.B
Nasdaq Stockholm
Laboratory Analytical Instruments
Global Rank
#46945
Country Rank
#746
Market Cap
2.61 M
Price
0.578
Change (%)
4.62%
Volume
12,935

Perpetua Medical AB (publ)'s latest marketcap:

2.61 M

As of 11/13/2025, Perpetua Medical AB (publ)'s market capitalization has reached $2.61 M. According to our data, Perpetua Medical AB (publ) is the 46945th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 2.61 M
Revenue (ttm) 1.9 M
Net Income (ttm) 420,539.48
Shares Out 4.52 M
EPS (ttm) 0.09
Forward PE 0.00
Ex-Dividend Date n/a
Earnings Date 11/14/2025
Market Cap Chart
Data Updated: 11/13/2025

Perpetua Medical AB (publ)'s yearly market capitalization.

Perpetua Medical AB (publ) has seen its market value drop from kr29.43 M to kr24.6 M since 2015, representing a total decrease of 16.43% and an annual compound decline rate (CAGR) of 1.80%.
Date Market Cap(kr) Market Cap(USD) Change (%) Global Rank
11/13/2025 kr24.6 M $2.61 M 21.5% 46945
12/30/2024 kr19.35 M $1.74 M 416.11% 43524
12/29/2023 kr3.75 M $369,727.03 -92.1% 43424
12/30/2022 kr47.47 M $4.53 M -66.03% 38562
12/30/2021 kr139.76 M $15.37 M 102.28% 33927
12/30/2020 kr69.09 M $8.36 M -9.58% 32649
12/30/2019 kr76.41 M $8.12 M 271.79% 29495
12/28/2018 kr20.55 M $2.31 M -75.33% 31160
11/16/2017 kr83.3 M $10.13 M 105.82% 27594
12/30/2016 kr40.47 M $4.43 M 37.5% 27046

Company Profile

About Perpetua Medical AB (publ)

Perpetua Medical AB (publ) is a Swedish company specializing in innovative solutions for injectable drug management. Headquartered in Uppsala, the company focuses on reducing medication errors and optimizing drug preparation processes.

Key Products & Solutions

  • DrugLog: A pharmacy solution designed to minimize medication errors.
  • WasteLog: A device that analyzes waste and returns of injectable controlled substances.
  • PrepLog: A DrugLog-based technology platform that integrates with prescription software for drug preparation testing.

Corporate Background

Originally founded as Pharmacolog i Uppsala AB (publ) in 2007, the company rebranded to Perpetua Medical AB (publ) in April 2024. It operates as a subsidiary of Nolsterby Invest AB.

Frequently Asked Questions

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Research Tools

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.